PharmaCCX Company
PharmaCCX is an independent, third-party technology platform created for the industry, by the industry. We are 100% focused on helping pharma and payers improve patient outcomes by more efficiently reaching access agreements in areas such as combination therapies, indication-based pricing, gene therapy and value-based deals. By using our platform, pharma companies make “contingent commitments” until they are able to agree on pricing with payers. We do not take sides — instead, we work collaboratively with all parties involved in a negotiation to help increase patient access to promising, life-saving therapies.
Total Funding:
3000000
Headquarters:
Boston, Massachusetts, United States
Funding Status:
Early Stage Venture
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series A
Technology:
Neurological Disorders
Founded Date:
2017-12-01
Industry:
Pharmtech